Literature DB >> 18342022

Transcriptional regulation of the 5'-flanking region of the human transcription factor Sp3 gene by NF-1, c-Myb, B-Myb, AP-1 and E2F.

Alicia Tapias1, Carlos J Ciudad, Véronique Noé.   

Abstract

We analyzed in detail the proximal promoter of transcription factor Sp3, which expands 281 bp from the translational start. This sequence contains putative binding sites for Sp1, NF-Y, NF-1, Myb, AP-1 and E2F transcription factors. In this work, we further explored the role of these boxes on the regulation of the Sp3 gene. Gel-shift and competition assays showed specific binding of NF-1, Myb, AP-1 and E2F. Furthermore, chromatin immunoprecipitation assays demonstrated that Sp1, Sp3, NF-Y, NF-1, c-Myb, B-Myb, c-Jun and E2F1 actually occupied the Sp3 promoter in HeLa cells. Transient transfections and luciferase assays revealed activation of the Sp3 proximal promoter upon overexpression of NF-1, c-Myb, B-Myb, c-Jun and c-Fos, and repression after overexpression of E2F/DP1. Point mutation of the binding sites for NF1, Myb, AP1 and E2F and cell incubation with specific siRNAs further confirmed the role of these transcription factors in the regulation of the Sp3 promoter. The regulation of the endogenous Sp3 gene was also observed at the mRNA level when the studied transcription factors were overexpressed or knocked down by siRNA incubation. These results help to explain the complex regulation of the Sp3 gene, which depends, at least in part, on the relative amount of Sp1, Sp3, NF-Y, NF-1, c-Myb, B-Myb, AP-1, and E2F proteins in the cell.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18342022     DOI: 10.1016/j.bbagrm.2008.02.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  CREB modulates calcium signaling in cAMP-induced bone marrow stromal cells (BMSCs).

Authors:  Linxia Zhang; Li Liu; Ryan Thompson; Christina Chan
Journal:  Cell Calcium       Date:  2014-08-06       Impact factor: 6.817

2.  CYP1A1 is overexpressed upon incubation of breast cancer cells with a polyphenolic cocoa extract.

Authors:  Carlota Oleaga; Miriam García; Anna Solé; Carlos J Ciudad; Maria Izquierdo-Pulido; Véronique Noé
Journal:  Eur J Nutr       Date:  2011-08-06       Impact factor: 5.614

3.  Regulation of Sp1 by cell cycle related proteins.

Authors:  Alicia Tapias; Carlos J Ciudad; Igor B Roninson; Véronique Noé
Journal:  Cell Cycle       Date:  2008-09-24       Impact factor: 4.534

Review 4.  Epigenetic mechanisms for the early environmental regulation of hippocampal glucocorticoid receptor gene expression in rodents and humans.

Authors:  Tie Yuan Zhang; Benoit Labonté; Xiang Lan Wen; Gustavo Turecki; Michael J Meaney
Journal:  Neuropsychopharmacology       Date:  2012-09-12       Impact factor: 7.853

5.  Aryl hydrocarbon receptor-induced activation of the human IGH hs1.2 enhancer: Mutational analysis of putative regulatory binding motifs.

Authors:  Andrew D Snyder; Sharon D Ochs; Brooke E Johnson; Courtney E W Sulentic
Journal:  Mol Immunol       Date:  2020-03-06       Impact factor: 4.407

6.  Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer.

Authors:  K Kim; G Chadalapaka; S-O Lee; D Yamada; X Sastre-Garau; P-A Defossez; Y-Y Park; J-S Lee; S Safe
Journal:  Oncogene       Date:  2011-07-18       Impact factor: 9.867

7.  Mathematical model of a telomerase transcriptional regulatory network developed by cell-based screening: analysis of inhibitor effects and telomerase expression mechanisms.

Authors:  Alan E Bilsland; Katrina Stevenson; Yu Liu; Stacey Hoare; Claire J Cairney; Jon Roffey; W Nicol Keith
Journal:  PLoS Comput Biol       Date:  2014-02-13       Impact factor: 4.475

8.  Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells.

Authors:  B Mitton; H-D Chae; K Hsu; R Dutta; G Aldana-Masangkay; R Ferrari; K Davis; B C Tiu; A Kaul; N Lacayo; G Dahl; F Xie; B X Li; M R Breese; E M Landaw; G Nolan; M Pellegrini; S Romanov; X Xiao; K M Sakamoto
Journal:  Leukemia       Date:  2016-05-23       Impact factor: 11.528

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.